Biopharmaceuticals

Ionis, AstraZeneca get FDA approval for uncommon genetic illness therapy

These advisers say markets predict unrealistic outcomes. Here are some options.

Wuxi XDC Cayman shares surge in Hong Kong debut

Stock movers: Snapchat, Theseus Pharmaceuticals, Azenta, Beauty Health, Fisker

AstraZeneca hikes earnings forecast as surging most cancers drug gross sales offset plunging income from COVID vaccines

Amgen will get FDA approval for its inflammatory ailments therapy Wezlana

Amgen’s inventory hit by expectations its weight problems pipeline is going through an extended wait

Ardelyx wins lengthy battle for FDA approval of kidney-disease remedy 

Pfizer shares fall on steerage reduce, weighing on BioNTech and Moderna shares, and different shares on the transfer

Pfizer’s inventory sinks after firm slashes $9 billion from outlook, foreshadows layoffs